Showing results (81-90 of 185) with videos related to
Sort By:
Pageof 19
Journal of Health Care for the Poor and Underserved|February 12, 2013
Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancerSyreeta L Tilghman, Lyndsay V Rhodes, Melyssa R Bratton, et al.Molecular Cancer|June 29, 2022
Ceritinib is a novel triple negative breast cancer therapeutic agentShengli Dong, Hassan Yousefi, Isabella Van Savage, et al.Journal of Cellular Biochemistry|August 30, 2019
Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancerThomas D Wright, Christopher Raybuck, Akshita Bhatt, et al.Molecular Carcinogenesis|June 8, 2011
Post-transcriptional up-regulation of miR-21 by type I collagenCui Li, Hong T Nguyen, Yan Zhuang, et al.Autophagy|August 5, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cellsM Danielle Bareford, Hossein A Hamed, Yong Tang, et al.Journal of Agricultural and Food Chemistry|April 3, 2003
Evaluation of the estrogenic effects of legume extracts containing phytoestrogensStephen M Boué, Thomas E Wiese, Suzanne Nehls, et al.Journal of Health Care for the Poor and Underserved|February 12, 2013
In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer modelsKiTani Parker Johnson, Letitia A Yearby, Diana Stoute, et al.Breast Cancer Research : BCR|November 2, 2013
Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathwaysAmy L Strong, Thomas A Strong, Lyndsay V Rhodes, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 16, 2015
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancerMelyssa R Bratton, Elizabeth C Martin, Steven Elliott, et al.Journal of Molecular Endocrinology|February 16, 2011
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancerJames W Antoon, William D Meacham, Melyssa R Bratton, et al.Pageof 19